Joining me on the call today to discuss our quarterly results are CEO, Mick Farrell and CFO, Brett Sandercock.
Other members of management will be available during the Q&A portion of the call.
During our call, we will discuss several non-GAAP measures.
We believe these statements are based on reasonable assumptions.
However, our actual results may differ.
Our team achieved another quarter of strong revenue growth across the portfolio driven by superb performance in the mask category particularly in the U.S. market with good performance across the 140 countries where we provide our solutions.
In addition, our Brightree and MatrixCare software systems are helping to manage 19 [Phonetic] million more people outside the hospital.
Digital health technology is an integrator across everything that ResMed does.
